rs11590590 - CCDST, FLG
Magnitude 2.2 · 1 study on file
Reported associations
-
Genome-Wide Integration of Genetic and Genomic Studies of Atopic Dermatitis: Insights into Genetic Architecture and Pathogenesis. - The Journal of investigative dermatology (2022) · Chen Y, Chen W · PubMed 35577104
Atopic dermatitis (AD) is a common heterogeneous, chronic, itching, and inflammatory skin disease. Genetic studies have identified multiple AD susceptibility genes. However, the genetic architecture of AD has not been elucidated. In this study, we conducted a large-scale meta-analysis of AD (35,647 cases and 1,013,885 controls) to characterize the genetic basis of AD. The heritability of AD in different datasets varied from 0.6 to 7.1%. We identified 31 previously unreported genes by integrating multiomics data. Among the 31 genes, MCL1 was identified as a potential treatment target for AD by mediating gene‒drug interactions. Tissue enrichment analyses and phenome-wide association study provided strong support for the role of the hemic and immune systems in AD. Across 1,207 complex trait
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Discuss with your doctor
-
filaggrin loss-of-function and atopic dermatitis risk High
Strong genetic association supports proactive discussion of barrier support and prevention strategies
Discuss with dermatologist; consider early intervention for symptom prevention
Lifestyle
-
daily moisturization and gentle skin care Moderate
Filaggrin dysfunction compromises barrier integrity; external moisture support mitigates impairment
Apply fragrance-free moisturizer to damp skin twice daily; use gentle, non-soap cleansers
Screening
-
atopic dermatitis symptoms and skin barrier High
FLG variants significantly impair skin barrier protein, elevating atopic dermatitis risk
Monitor for persistent itching, redness, dryness; seek dermatology if symptoms develop